350 related articles for article (PubMed ID: 34880488)
1. Omicron likely to weaken COVID vaccine protection.
Callaway E
Nature; 2021 Dec; 600(7889):367-368. PubMed ID: 34880488
[No Abstract] [Full Text] [Related]
2. Scientists see a 'really, really tough winter' with Omicron.
Kupferschmidt K
Science; 2021 Dec; 374(6574):1421-1422. PubMed ID: 34914506
[No Abstract] [Full Text] [Related]
3. Coronavirus variants are spreading in India - what scientists know so far.
Vaidyanathan G
Nature; 2021 May; 593(7859):321-322. PubMed ID: 33976409
[No Abstract] [Full Text] [Related]
4. 'Killer' immune cells still recognize Omicron variant.
Ledford H
Nature; 2022 Jan; 601(7893):307. PubMed ID: 35017690
[No Abstract] [Full Text] [Related]
5. New Omicron begins to take over, despite late start.
Wadman M
Science; 2022 Feb; 375(6580):480-481. PubMed ID: 35113702
[TBL] [Abstract][Full Text] [Related]
6. Pfizer COVID vaccine protects against worrying coronavirus variants.
Callaway E
Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
[No Abstract] [Full Text] [Related]
7. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
Planas D; Saunders N; Maes P; Guivel-Benhassine F; Planchais C; Buchrieser J; Bolland WH; Porrot F; Staropoli I; Lemoine F; Péré H; Veyer D; Puech J; Rodary J; Baele G; Dellicour S; Raymenants J; Gorissen S; Geenen C; Vanmechelen B; Wawina-Bokalanga T; Martí-Carreras J; Cuypers L; Sève A; Hocqueloux L; Prazuck T; Rey FA; Simon-Loriere E; Bruel T; Mouquet H; André E; Schwartz O
Nature; 2022 Feb; 602(7898):671-675. PubMed ID: 35016199
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccine breakthrough infections.
Gupta RK; Topol EJ
Science; 2021 Dec; 374(6575):1561-1562. PubMed ID: 34941414
[TBL] [Abstract][Full Text] [Related]
9. Evolving threat.
Kupferschmidt K
Science; 2021 Aug; 373(6557):844-849. PubMed ID: 34413220
[No Abstract] [Full Text] [Related]
10. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
Hansen CB; Jarlhelt I; Hasselbalch RB; Hamm SR; Fogh K; Pries-Heje MM; Møller DL; Heftdal LD; Pérez-Alós L; Sørensen E; Larsen MAH; Skjoedt MO; Ostrowski SR; Frikke-Schmidt R; Bayarri-Olmos R; Hilsted LM; Bundgaard H; Nielsen SD; Iversen KK; Garred P
J Intern Med; 2021 Dec; 290(6):1272-1274. PubMed ID: 34237190
[No Abstract] [Full Text] [Related]
11. Neutralizing SARS-CoV-2.
Poeschla E
Elife; 2020 Dec; 9():. PubMed ID: 33320086
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
Cevik M; Grubaugh ND; Iwasaki A; Openshaw P
Cell; 2021 Sep; 184(20):5077-5081. PubMed ID: 34534444
[TBL] [Abstract][Full Text] [Related]
13. Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma.
Wang Y; Ma Y; Xu Y; Liu J; Li X; Chen Y; Chen Y; Xie J; Xiao L; Xiang Z; Wu F; Huang J
Emerg Microbes Infect; 2022 Dec; 11(1):424-427. PubMed ID: 35001836
[No Abstract] [Full Text] [Related]
14. Steep Decline in Binding Capability of SARS-CoV-2 Omicron Variant (B.1.1.529) RBD to the Antibodies in Early COVID-19 Convalescent Sera and Inactivated Vaccine Sera.
Zhou W; He P; Li J; Liu H; Shi M; Yu J; Wei H
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215927
[TBL] [Abstract][Full Text] [Related]
15. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.
Wang Y
EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128
[No Abstract] [Full Text] [Related]
16. Beyond Omicron: what's next for COVID's viral evolution.
Callaway E
Nature; 2021 Dec; 600(7888):204-207. PubMed ID: 34876665
[No Abstract] [Full Text] [Related]
17. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
Zhou X; Wang H; Ji Q; Du M; Liang Y; Li H; Li F; Shang H; Zhu X; Wang W; Jiang L; Stepanov AV; Ma T; Gong N; Jia X; Gabibov AG; Lou Z; Lu Y; Guo Y; Zhang H; Yang X
Protein Cell; 2021 Oct; 12(10):818-823. PubMed ID: 33909239
[No Abstract] [Full Text] [Related]
18. COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer.
Zeng C; Evans JP; Chakravarthy K; Qu P; Reisinger S; Song NJ; Rubinstein MP; Shields PG; Li Z; Liu SL
Cancer Cell; 2022 Feb; 40(2):117-119. PubMed ID: 34986328
[No Abstract] [Full Text] [Related]
19. Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.
Yue L; Zhou J; Zhou Y; Yang X; Xie T; Yang M; Zhao H; Zhao Y; Yang T; Li H; Xiang H; Wang J; Lu S; Liu H; Zhao H; Wei X; Zhang Y; Xie Z
Emerg Microbes Infect; 2021 Dec; 10(1):2125-2127. PubMed ID: 34666622
[No Abstract] [Full Text] [Related]
20. Plasma Neutralization of the SARS-CoV-2 Omicron Variant.
Schmidt F; Muecksch F; Weisblum Y; Da Silva J; Bednarski E; Cho A; Wang Z; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
N Engl J Med; 2022 Feb; 386(6):599-601. PubMed ID: 35030645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
